These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12132441)

  • 41. Nevirapine warning on post-exposure prophylaxis.
    AIDS Treat News; 2001 Jan; (358):6-8. PubMed ID: 12173559
    [TBL] [Abstract][Full Text] [Related]  

  • 42. FDA notifications. Gilead issues letter about virologic failure.
    AIDS Alert; 2003 Dec; 18(12):159-60. PubMed ID: 14696542
    [No Abstract]   [Full Text] [Related]  

  • 43. Pharmacokinetics and safety of stavudine in HIV-infected pregnant women and their infants: Pediatric AIDS Clinical Trials Group protocol 332.
    Wade NA; Unadkat JD; Huang S; Shapiro DE; Mathias A; Yasin S; Ciupak G; Watts DH; Delke I; Rathore M; Hitti J; Frenkel L; Samelson R; Smith ME; Mofenson L; Burchett SK
    J Infect Dis; 2004 Dec; 190(12):2167-74. PubMed ID: 15551216
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Meeting notes from ICAAC. Tenofovir + ddI: a combination to avoid.
    Sax PE
    AIDS Clin Care; 2005 Jan; 17(1):6-7. PubMed ID: 15717372
    [No Abstract]   [Full Text] [Related]  

  • 45. Mitochondrial DNA depletion in adipose tissue of HIV-infected patients with peripheral lipoatrophy.
    Buffet M; Schwarzinger M; Amellal B; Gourlain K; Bui P; Prévot M; Deleuze J; Morini JP; Gorin I; Calvez V; Dupin N
    J Clin Virol; 2005 May; 33(1):60-4. PubMed ID: 15797366
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relative mutagenic potencies of several nucleoside analogs, alone or in drug pairs, at the HPRT and TK loci of human TK6 lymphoblastoid cells.
    Carter MM; Torres SM; Cook DL; McCash CL; Yu M; Walker VE; Walker DM
    Environ Mol Mutagen; 2007; 48(3-4):239-47. PubMed ID: 17358029
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro analysis of synergism and antagonism of different nucleoside/nucleotide analogue combinations on the inhibition of human immunodeficiency virus type 1 replication.
    Perez-Olmeda M; Garcia-Perez J; Mateos E; Spijkers S; Ayerbe MC; Carcas A; Alcami J
    J Med Virol; 2009 Feb; 81(2):211-6. PubMed ID: 19107982
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Virammune and women in the news.
    Emery C
    Surviv News (Atlanta Ga); 2005; 16(2):10. PubMed ID: 16158512
    [No Abstract]   [Full Text] [Related]  

  • 49. FDA notifications. New labeling for Videx pediatric powder.
    AIDS Alert; 2009 Aug; 24(8):94-6. PubMed ID: 19705588
    [No Abstract]   [Full Text] [Related]  

  • 50. Combination therapy for patients with HIV-1 infection: the use of dual nucleoside analogues with protease inhibitors and other agents.
    Gulick R
    AIDS; 1998; 12 Suppl 3():S17-22. PubMed ID: 15168719
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Didanosine (Videx).
    Res Initiat Treat Action; 2000 Mar; 6(1):8-9. PubMed ID: 11708189
    [No Abstract]   [Full Text] [Related]  

  • 52. FDA notifications. FDA grants tentative approval to two ART drugs under expedited review.
    AIDS Alert; 2007 May; 22(5):57. PubMed ID: 17580369
    [No Abstract]   [Full Text] [Related]  

  • 53. Side effects. Protease inhibitors and pregnancy--reports from the U.S.
    TreatmentUpdate; 2001; 12(9):6. PubMed ID: 12132448
    [No Abstract]   [Full Text] [Related]  

  • 54. Risk factors for lactic acidosis in HIV-infected patients treated with nucleoside reverse-transcriptase inhibitors: a case-control study.
    Bonnet F; Bonarek M; Morlat P; Mercié P; Dupon M; Gemain MC; Malvy D; Bernard N; Pellegrin JL; Beylot J
    Clin Infect Dis; 2003 May; 36(10):1324-8. PubMed ID: 12746780
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gynaecomastia in a male patient during stavudine and didanosine treatment for HIV infection.
    Aquilina C; Viraben R
    Int J STD AIDS; 2001 Jul; 12(7):481-2. PubMed ID: 11394987
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A very, very short of breath HIV-infected patient].
    Mégarbane B; Fromont C; Nion I; Chary I; Axler O; Slama A; Brivet M; Rustin P; Munnich A; Brivet F
    Rev Med Interne; 1999; 20 Suppl 2():256s-259s. PubMed ID: 10422161
    [No Abstract]   [Full Text] [Related]  

  • 57. French investigators warn of LPV/TDF/ddI interaction.
    Carter M
    IAPAC Mon; 2003 Dec; 9(12):315. PubMed ID: 15055164
    [No Abstract]   [Full Text] [Related]  

  • 58. It's time to face the Zerit problem.
    Vergel N
    GMHC Treat Issues; 2003 Mar; 17(3):12. PubMed ID: 12728861
    [No Abstract]   [Full Text] [Related]  

  • 59. Stavudine in antiretroviral therapy: is this the end?
    Brinkman K
    AIDS; 2009 Aug; 23(13):1727-9. PubMed ID: 19571724
    [No Abstract]   [Full Text] [Related]  

  • 60. What a difference a day makes.
    Huff B
    GMHC Treat Issues; 2001; 15(11-12):15. PubMed ID: 11819967
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.